Droplet microfluidic screening to engineer angiotensin-converting enzyme 2 (ACE2) catalytic activity
Abstract Background Angiotensin-Converting Enzyme 2 (ACE2) is a crucial peptidase in human peptide hormone signaling, catalyzing the conversion of Angiotensin-II to Angiotensin-(1–7), which activates the Mas receptor and elicits vasodilation, increased blood flow, reduced inflammation, and decreased...
Saved in:
Main Authors: | Evelyn F Okal, Philip A. Romero, Pete Heinzelman |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | Journal of Biological Engineering |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13036-025-00482-3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Angiotensin I converting enzyme (ACE) inhibitory activity and antihypertensive effects of rice peptides
by: Jingjing Dong, et al.
Published: (2022-11-01) -
Druggability and molecular docking of essential secondary metabolites from Azadirachta indica leaf against angiotensin converting enzyme-2: Covid-19 in focus
by: Paul Chijioke Ozioko, et al.
Published: (2025-02-01) -
Optimization of Protein Hydrolysate from Earthworms (<i>Perionyx excavatus</i>) of Angiotensin-I-Converting Enzyme Inhibitory Activity by One Variable at a Time
by: Phong Thanh Bui, et al.
Published: (2025-01-01) -
Effect of angiotensin-converting enzyme inhibitors versus that of angiotensin receptor blockers on survival in patients undergoing hemodialysis: a nationwide observational cohort study
by: Seok Hui Kang, et al.
Published: (2024-12-01) -
Evaluation of Biologics ACE2/Ang(1–7) Encapsulated in Plant Cells for FDA Approval: Safety and Toxicology Studies
by: Henry Daniell, et al.
Published: (2024-12-01)